Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Philip Hansten
Long-Term Safety of Hepatic Hydroxymethyl Glutaryl Coenzyme a Reductase Inhibitors
Archives of Internal Medicine
Related publications
Inhibitors of Hydroxymethylglutaryl Coenzyme a Reductase for Treating Hypercholesterolaemia.
BMJ
3-Hydroxy-3-Methylglutaryl–coenzyme a Reductase Inhibitors (Statins) Induce Hepatic Expression of the Phospholipid Translocase Mdr2 in Rats
Gastroenterology
Hepatology
Gastroenterology
Prevention of Atrial Fibrillation With 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase Inhibitors
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors
Journal of Clinical Medicine Research
Effect of Hydroxymethylglutaryl Coenzyme a Reductase Inhibitors on the Progression of Calcific Aortic Stenosis
Circulation
Cardiovascular Medicine
Physiology
Cardiology
3-Hydroxy-3-Methyl Glutaryl Coenzyme a Reductase Inhibition Modulates Vasopressin-Stimulated Ca2+ Responses in Rat A10 Vascular Smooth Muscle Cells
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology
3-Hydroxy-3 Methyl Glutaryl Coenzyme a (Hmg Coa) Reductase Activity in Fibroblasts From Phenotypic Homozygous Type Ii Hy-Perlipoproteinemia (Hhlpii)
Pediatric Research
Child Health
Pediatrics
Perinatology
Varicose Remodeling of Veins Is Suppressed by 3‐Hydroxy‐3‐Methylglutaryl Coenzyme a Reductase Inhibitors
Journal of the American Heart Association
Cardiovascular Medicine
Cardiology
Pharmacokinetic Interactions Between Nelfinavir and 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase Inhibitors Atorvastatin and Simvastatin
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology